← Back to Search

Pedi-Cap for Neonatal Disease (CO2-Vent Trial)

N/A
Recruiting
Led By Riti Chokshi
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from birth to date of discharge or death, whichever comes first, assessed up to 50 weeks
Awards & highlights

CO2-Vent Trial Summary

This trial aims to see if using a colorimetric carbon dioxide detector called Pedi-Cap during face mask ventilation for newborn infants can reduce the time needed for ventilation. The study will involve a neon

Who is the study for?
This trial is for newborn infants born at or after 30 weeks' gestation who need non-invasive positive pressure ventilation (PPV) in the delivery room. The neonatal resuscitation team must be present before delivery to participate.Check my eligibility
What is being tested?
The study tests if using a Pedi-Cap, which detects carbon dioxide, can reduce the time newborns need face mask PPV in the delivery room. Infants are randomly assigned monthly to either use or not use the Pedi-Cap during PPV.See study design
What are the potential side effects?
There are no direct side effects from using a Pedi-Cap as it's a non-invasive monitoring device. However, its usage may influence decisions on how long to continue PPV.

CO2-Vent Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from birth to date of discharge or death, whichever comes first, assessed up to 50 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and from birth to date of discharge or death, whichever comes first, assessed up to 50 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of positive pressure ventilation (PPV)
Secondary outcome measures
Duration of bradycardia
Duration of mechanical ventilation
Maximum peak inspiratory pressure used
+9 more
Other outcome measures
Initial heart rate at birth

CO2-Vent Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pedi-CapExperimental Treatment1 Intervention
A Pedi-Cap will be connected to the T-piece resuscitator in between the T-piece and face mask. With effective gas exchange, carbon dioxide (CO2) is detected by the Pedi-cap and will demonstrate gold color change with each exhalation. If there is no CO2 gas exchanged, the Pedi-Cap color will remain purple. The color change will be used as one of the tools for the resuscitation team to determine if the infant has effective non-invasive positive pressure ventilation (PPV) during delivery room resuscitation. Other ways, in addition to the Pedi-Cap, to determine effective PPV include a rise in heart rate, improved infant color, chest rise, and improvement in oxygen saturation.
Group II: No Pedi-CapActive Control1 Intervention
There will be no Pedi-Cap attached to the t-piece resuscitator. Effective non-invasive positive pressure ventilation (PPV) during delivery room resuscitation will be assessed by a rise in heart rate, improved infant color, chest rise, and improvement in oxygen saturation.

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,048 Previous Clinical Trials
1,053,103 Total Patients Enrolled
Riti ChokshiPrincipal InvestigatorUniversity of Texas

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently able to participate in this ongoing trial?

"As per information from clinicaltrials.gov, this research project is actively seeking volunteers. The trial was initially listed on March 1st, 2024 and most recently revised on March 10th, 2024."

Answered by AI

What is the current number of individuals being recruited for participation in this research study?

"Indeed, information available on clinicaltrials.gov highlights the ongoing recruitment of participants for this clinical trial. The trial was initially posted on March 1st, 2024, and most recently updated on March 10th, 2024. It aims to enroll a total of 632 individuals at a single designated site."

Answered by AI
~421 spots leftby Jul 2025